Archive

Search Results

We have found 559 releases for the category General.

	release title	release date
	Acousia Therapeutics to present its first-in-class hearing loss treatment program with ACOU085 at the 2nd Inner Ear Therapeutics Summit in Boston	11/05/2022
	Evaluate appoints Matthew Wright as Chief Financial Officer multimedia	11/05/2022
	Evaluate report signals orphan drug market is niche no more multimedia	28/04/2022
	'Digital health' investments surged by 79 per cent in 2021, says Hampleton Partners' Healthtech Report multimedia	21/04/2022
	Evaluate announces global strategic collaboration with Treehill Partners multimedia	21/04/2022
	HPDC Launches the World's First All-in-One Supply Chain Management Solution for Advanced & Personalized Therapies	05/04/2022
	Is microplastic carcinogenic?	30/03/2022
	Grünenthal and NovaQuest enter agreement to advance the resiniferatoxin global Phase III program in osteoarthritis	29/03/2022
	Grünenthal donates 400.000€ and provides pain treatment medicine to Ukraine	07/03/2022
	Hearing loss company Acousia Therapeutics to present data for ACOU085 at ARO 2022 MidWinter Meeting February 5–9	26/01/2022
	R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation multimedia	07/12/2021
	Global Research Institute with new Professorship in Tropical Medicine and Focus on Implementation Research	03/12/2021
	nal von minden develops a rapid test for colorectal cancer screening multimedia	16/11/2021
	BridgeHead and Eclipse Advance Healthcare Integration with Clinical Trials multimedia	16/11/2021
	German MECOTEC Group delivers 8 containers for deep-freeze storage of Covid-Vaccines multimedia	02/11/2021
	‘Pick and mix’ technology promises future-proof universal vaccines against COVID and more multimedia	02/11/2021
	The flu or corona? Combination rapid test provides answers in just 15 minutes multimedia	08/10/2021
	First participants enrolled in Clinical Trial with Nociceptin/Orphanin peptide receptor (NOP) agonist	29/09/2021
	Have your antibodies checked before receiving a third vaccine dose multimedia	31/08/2021
	First patient enrolled in a Phase III study with QUTENZA® in post-surgical neuropathic pain	10/08/2021

---